A Prospective Analysis of DAXX/ATRX Testing for Surgically Resected Pancreatic Neuroendocrine Tumors Reveals Loss of Expression for DAXX/ATRX is Associated with the Development of Metastatic Disease

被引：0
|
作者：
Bell, Phoenix [1 ]
Smith, Katelyn [1 ]
Singhi, Aatur [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1451
引用
收藏
页码：S1815 / S1816
页数：2
相关论文
共 50 条
  • [31] DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
    Jiao, Yuchen
    Shi, Chanjuan
    Edil, Barish H.
    de Wilde, Roeland F.
    Klimstra, David S.
    Maitra, Anirban
    Schulick, Richard D.
    Tang, Laura H.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Velculescu, Victor E.
    Diaz, Luis A., Jr.
    Vogelstein, Bert
    Kinzler, Kenneth W.
    Hruban, Ralph H.
    Papadopoulos, Nickolas
    SCIENCE, 2011, 331 (6021) : 1199 - 1203
  • [32] ATRX/DAXX Status on Diagnostic FNA Informs Progression Free Survival Prognostication in Pancreatic Neuroendocrine Tumors
    Hedberg, Matthew
    Bernadt, Cory
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 366 - 366
  • [33] The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2022, 129 : 11 - 20
  • [34] Characterization of 142 Human Pancreatic Neuroendocrine Tumors: ATRX and DAXX Correlation with Clinical-Pathological Data
    Gaspar, T. B.
    Pinheiro, J.
    Canberk, S.
    Ince, U.
    Tokat, F.
    Lopes, J. M.
    Maximo, V
    Soares, P.
    Vinagre, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 9 - 9
  • [35] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    LABORATORY INVESTIGATION, 2015, 95 : 449A - 449A
  • [36] Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region
    Casar-Borota, Olivera
    Botling, Johan
    Granberg, Dan
    Stigare, Jerker
    Wikstrom, Johan
    Boldt, Henning Bunsow
    Kristensen, Bjarne Winther
    Ponten, Fredrik
    Trouillas, Jacqueline
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (09) : 1238 - 1246
  • [37] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    MODERN PATHOLOGY, 2015, 28 : 449A - 449A
  • [38] Investigating the Molecular and Phenotypic Differences in Pancreatic Neuroendocrine Tumor (PanNET) Cells with Functional Loss of Either ATRX or DAXX
    Nelson, Elizabeth B.
    Stojanova, Marija
    Heaphy, Christopher M.
    FASEB JOURNAL, 2022, 36
  • [39] ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
    Chan, Chang S.
    Laddha, Saurabh, V
    Lewis, Peter W.
    Koletsky, Matthew S.
    Robzyk, Kenneth
    Da Silva, Edaise
    Torres, Paula J.
    Untch, Brian R.
    Li, Janet
    Bose, Promita
    Chan, Timothy A.
    Klimstra, David S.
    Allis, C. David
    Tang, Laura H.
    NATURE COMMUNICATIONS, 2018, 9
  • [40] ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
    Chang S. Chan
    Saurabh V. Laddha
    Peter W. Lewis
    Matthew S. Koletsky
    Kenneth Robzyk
    Edaise Da Silva
    Paula J. Torres
    Brian R. Untch
    Janet Li
    Promita Bose
    Timothy A. Chan
    David S. Klimstra
    C. David Allis
    Laura H. Tang
    Nature Communications, 9
12345